Glen Santangelo
Stock Analyst at Jefferies
(2.49)
# 3,104
Out of 4,944 analysts
76
Total ratings
46.81%
Success rate
1.72%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $7.44 | +7.53% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $88.74 | -9.85% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $10.41 | +24.88% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $35.35 | +44.27% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $7.28 | -17.58% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $21.56 | +2.04% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $13.85 | +44.40% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $24.96 | -27.87% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $23.06 | +4.08% | 4 | Sep 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $48.33 | -52.41% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $17.21 | +33.64% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $37.86 | +16.22% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $17.81 | -4.55% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $152.44 | +50.88% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $6.59 | +1,417.45% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $30.48 | +129.66% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $15.46 | +255.87% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $10.48 | +52.67% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $4.78 | +192.89% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $64.02 | -28.15% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $89.27 | -10.38% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $3.22 | +769.57% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $28.65 | +144.33% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $7.19 | +1,568.98% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.58 | -22.48% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $3.56 | +1,220.22% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.94 | +813.71% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $65.90 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $663.17 | -74.52% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $148.12 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $68.99 | +18.86% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $145.74 | +71.54% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $11.89 | +556.01% | 1 | Dec 4, 2017 |
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $7.44
Upside: +7.53%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $88.74
Upside: -9.85%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $10.41
Upside: +24.88%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $35.35
Upside: +44.27%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $7.28
Upside: -17.58%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $21.56
Upside: +2.04%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $13.85
Upside: +44.40%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $24.96
Upside: -27.87%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $23.06
Upside: +4.08%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $48.33
Upside: -52.41%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $17.21
Upside: +33.64%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $37.86
Upside: +16.22%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $17.81
Upside: -4.55%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $152.44
Upside: +50.88%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $6.59
Upside: +1,417.45%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $30.48
Upside: +129.66%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $15.46
Upside: +255.87%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $10.48
Upside: +52.67%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $4.78
Upside: +192.89%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $64.02
Upside: -28.15%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $89.27
Upside: -10.38%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $3.22
Upside: +769.57%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $28.65
Upside: +144.33%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $7.19
Upside: +1,568.98%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.58
Upside: -22.48%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $3.56
Upside: +1,220.22%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $3.94
Upside: +813.71%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $65.90
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $663.17
Upside: -74.52%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $148.12
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $68.99
Upside: +18.86%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $145.74
Upside: +71.54%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $11.89
Upside: +556.01%